Analysis of inhibition of topoisomerase IIalpha and cancer cell proliferation by ingenolEZ. 2010

Chisato Yoshida, and Kazsuyoshi Hishiyama, and Khosuke Miyazaki, and Manami Watanabe, and Masahiro Kanbe, and Yuta Yamada, and Keiithi Matsuzaki, and Kiichi Miyashita, and Susumu Kitanaka, and Shohei Miyata
Department of Chemistry, College of Humanities and Sciences, Nihon University, Tokyo, Japan.

We previously reported that many ingenol compounds derived from Euphorbia kansui exhibit topoisomerase inhibitory activity and/or inhibitory activity of cell proliferation. The inhibitory effects of 20-O-(2'E,4'Z-decadienoyl) ingenol and 3-O-(2'E,4'Z-decadienoyl)-ingenol among these compounds on topoisomerase II activity and on the cell proliferative activity and arrest phase of the cell cycle were studied using a mouse breast cancer (MMT) cell line. Although 20-O-ingenolEZ exerted inhibitory effects on both topoisomerase II activity and cell proliferative activity, 3-O-ingenolEZ exerted inhibitory activity on neither. The 20-O-ingenolEZ-induced cell arrest of MMT-cell proliferation led to a cell cycle arrest in the G2/M phase. Topoisomerase II inhibition can be divided into the poison and catalytic inhibitor types. A checkpoint mechanism is activated when cells are treated with these topoisomerase II inhibitors. Poison-type inhibition occurs via induction of the DNA damage checkpoint and the catalytic-type inhibition occurs via induction of the DNA-decatenation checkpoint, suggestive of distinct checkpoint reactions. 20-O-ingenolEZ inhibited topoisomerase IIalpha activity through inhibition of ATPase, and induced DNA-decatenation checkpoint without signaling for phosphorylation of H2AX.

UI MeSH Term Description Entries
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D004224 Diterpenes Twenty-carbon compounds derived from MEVALONIC ACID or deoxyxylulose phosphate. Diterpene,Diterpenes, Cembrane,Diterpenes, Labdane,Diterpenoid,Labdane Diterpene,Norditerpene,Norditerpenes,Norditerpenoid,Cembranes,Diterpenoids,Labdanes,Norditerpenoids,Cembrane Diterpenes,Diterpene, Labdane,Labdane Diterpenes
D004250 DNA Topoisomerases, Type II DNA TOPOISOMERASES that catalyze ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. These enzymes bring about relaxation of the supercoiled DNA and resolution of a knotted circular DNA duplex. DNA Topoisomerase (ATP-Hydrolysing),DNA Topoisomerase II,DNA Topoisomerase II alpha,DNA Topoisomerase II beta,DNA Type 2 Topoisomerase,TOP2A Protein,TOP2B Protein,Topoisomerase II,Topoisomerase II alpha,Topoisomerase II beta,Type II DNA Topoisomerase,alpha, Topoisomerase II,beta, Topoisomerase II
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D000972 Antineoplastic Agents, Phytogenic Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. Antineoplastics, Botanical,Antineoplastics, Phytogenic,Agents, Phytogenic Antineoplastic,Botanical Antineoplastics,Phytogenic Antineoplastic Agents,Phytogenic Antineoplastics
D016195 G2 Phase The period of the CELL CYCLE following DNA synthesis (S PHASE) and preceding M PHASE (cell division phase). The CHROMOSOMES are tetraploid in this point. Gap Phase 2,Second Gap Phase,G2 Phases,Gap Phase, Second,Gap Phases, Second,Phase 2, Gap,Phase, G2,Phase, Second Gap,Phases, G2,Phases, Second Gap,Second Gap Phases
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Chisato Yoshida, and Kazsuyoshi Hishiyama, and Khosuke Miyazaki, and Manami Watanabe, and Masahiro Kanbe, and Yuta Yamada, and Keiithi Matsuzaki, and Kiichi Miyashita, and Susumu Kitanaka, and Shohei Miyata
June 2005, Biochemical and biophysical research communications,
Chisato Yoshida, and Kazsuyoshi Hishiyama, and Khosuke Miyazaki, and Manami Watanabe, and Masahiro Kanbe, and Yuta Yamada, and Keiithi Matsuzaki, and Kiichi Miyashita, and Susumu Kitanaka, and Shohei Miyata
April 2001, Toxicology letters,
Chisato Yoshida, and Kazsuyoshi Hishiyama, and Khosuke Miyazaki, and Manami Watanabe, and Masahiro Kanbe, and Yuta Yamada, and Keiithi Matsuzaki, and Kiichi Miyashita, and Susumu Kitanaka, and Shohei Miyata
July 2009, International journal of molecular sciences,
Chisato Yoshida, and Kazsuyoshi Hishiyama, and Khosuke Miyazaki, and Manami Watanabe, and Masahiro Kanbe, and Yuta Yamada, and Keiithi Matsuzaki, and Kiichi Miyashita, and Susumu Kitanaka, and Shohei Miyata
September 2002, Toxicological sciences : an official journal of the Society of Toxicology,
Chisato Yoshida, and Kazsuyoshi Hishiyama, and Khosuke Miyazaki, and Manami Watanabe, and Masahiro Kanbe, and Yuta Yamada, and Keiithi Matsuzaki, and Kiichi Miyashita, and Susumu Kitanaka, and Shohei Miyata
December 1999, The Biochemical journal,
Chisato Yoshida, and Kazsuyoshi Hishiyama, and Khosuke Miyazaki, and Manami Watanabe, and Masahiro Kanbe, and Yuta Yamada, and Keiithi Matsuzaki, and Kiichi Miyashita, and Susumu Kitanaka, and Shohei Miyata
September 2011, Journal of UOEH,
Chisato Yoshida, and Kazsuyoshi Hishiyama, and Khosuke Miyazaki, and Manami Watanabe, and Masahiro Kanbe, and Yuta Yamada, and Keiithi Matsuzaki, and Kiichi Miyashita, and Susumu Kitanaka, and Shohei Miyata
June 1996, The American journal of pathology,
Chisato Yoshida, and Kazsuyoshi Hishiyama, and Khosuke Miyazaki, and Manami Watanabe, and Masahiro Kanbe, and Yuta Yamada, and Keiithi Matsuzaki, and Kiichi Miyashita, and Susumu Kitanaka, and Shohei Miyata
March 2005, Molecular pharmacology,
Chisato Yoshida, and Kazsuyoshi Hishiyama, and Khosuke Miyazaki, and Manami Watanabe, and Masahiro Kanbe, and Yuta Yamada, and Keiithi Matsuzaki, and Kiichi Miyashita, and Susumu Kitanaka, and Shohei Miyata
September 2001, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
Chisato Yoshida, and Kazsuyoshi Hishiyama, and Khosuke Miyazaki, and Manami Watanabe, and Masahiro Kanbe, and Yuta Yamada, and Keiithi Matsuzaki, and Kiichi Miyashita, and Susumu Kitanaka, and Shohei Miyata
January 2008, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
Copied contents to your clipboard!